EC
GMED icon

EntryPoint Capital’s Globus Medical GMED Stock Holding History

EntryPoint Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,869
Closed -$283K – 690
2025
Q1 		$283K Buy
+3,869
New +$320K 0.13% 352
2024
Q3 		– Sell
-1,069
Closed -$73.2K – 813
2024
Q2 		$73.2K Buy
+1,069
New +$63.9K 0.11% 436

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

EntryPoint Capital's GMED Position: Q2 2025 in Review

EntryPoint Capital sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 3,869 shares — an estimated $283K sold.

EntryPoint Capital first reported a position in GMED in Q2 2024 and held it in 2 quarters. The position peaked at $283K in Q1 2025. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • EntryPoint Capital reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • EntryPoint Capital sold 3,869 Globus Medical shares in Q2 2025, an estimated $283K.
  • EntryPoint Capital first reported a position in Globus Medical in Q2 2024 and held it in 2 quarters.
  • EntryPoint Capital's Globus Medical position peaked at $283K in Q1 2025.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on EntryPoint Capital's 13F filing for Q2 2025, filed 11 Aug 2025.